Perspectum, a precision health company which develops medical imaging tools to improve the diagnosis of metabolic diseases and cancer, has raised £30 million Series C funding. Led by Oppenheimer Holdings, it brings the total amount raised since the Oxford company’s inception to $120m. Since the beginning of 2021, 77 million US adults covered by Medicare … Continue reading £30m funding for disease diagnosis firm Perspectum